You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Squamous Cell Carcinoma of Pancreas

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

Completed
  • Advanced Solid Tumors
  • +17 more
  • San Diego, California
  • +3 more
Jan 27, 2023

Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

Recruiting
  • Carcinoma
  • +18 more
  • PEN-866 Sodium
  • +3 more
  • Springdale, Arkansas
  • +15 more
Feb 16, 2022

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

Not yet recruiting
  • Squamous Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Jun 23, 2023

    Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • no intervention
    • Wuhan, Hubei, China
      Renmin hosptial of Wuhan University
    Jul 29, 2023

    Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

    Not yet recruiting
    • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
    • Guangzhou, Guangdong, China
      Sun Yat-sen University
    Oct 24, 2023

    Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

    Recruiting
    • Esophageal Squamous Cell Carcinoma
      • Shijiazhuang, Hebei, China
        Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
      Oct 25, 2023

      Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Nov 30, 2023

      Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

      Not yet recruiting
      • Solid Tumor, Adult
      • +15 more
      • A2B530
      • xT-Onco with HLA-LOH Assay
      • Duarte, California
      • +6 more
      Feb 10, 2023

      Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

      Not yet recruiting
      • Squamous Cell Carcinoma of the Skin
      • Carrilizumab with albumin-binding paclitaxel
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      May 23, 2023

      Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
      • (no location specified)
      Mar 17, 2023

      Long-term, Non-interventional, Observational Study Following

      Recruiting
      • Advanced Solid Tumor
      • +17 more
      • Allogeneic natural killer (NK) cell
      • San Diego, California
      • +3 more
      Oct 15, 2021

      Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

      Not yet recruiting
      • Locally Advanced Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Mar 20, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Carrilizumab, bevacizumab,capecitabine
      • (no location specified)
      Jul 20, 2023

      Cutaneous Squamous Cell Carcinoma Trial (INCB099280)

      Not yet recruiting
      • Cutaneous Squamous Cell Carcinoma
      • (no location specified)
      May 24, 2023

      The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

      Recruiting
      • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
      • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
      • Hanzhou, Zhejiang, China
        Lulu Liu
      Jul 14, 2023

      Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • PET/CT
      • Neck dissection
      • (no location specified)
      Jan 31, 2023

      Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)

      Recruiting
      • Oral Squamous Cell Carcinoma
      • Oral Mucositis
      • Alfacalcidol Oral Solution
      • Placebo
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital
      Aug 24, 2023

      Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

      Not yet recruiting
      • Advanced Esophageal Squamous Carcinoma With Oligometastases
      • simultaneous with radiotherapy
      • synchronous with radiotherapy
      • (no location specified)
      Nov 16, 2023

      Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
      • (no location specified)
      Aug 17, 2023

      Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +3 more
      • Guangzhou, Guangdong, China
      • +4 more
      Nov 16, 2023

      Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Locally Advanced Operable
      • Guangzhou, Guangdong, China
      • +1 more
      Sep 4, 2023

      Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
        • Hangzhou, Zhejiang, China
          Second Affiliated Hospital, School of Medicine, Zhejiang Univers
        Aug 22, 2023